[go: up one dir, main page]

IS1980B - Use of Melatonin to treat drug addicts - Google Patents

Use of Melatonin to treat drug addicts

Info

Publication number
IS1980B
IS1980B IS4532A IS4532A IS1980B IS 1980 B IS1980 B IS 1980B IS 4532 A IS4532 A IS 4532A IS 4532 A IS4532 A IS 4532A IS 1980 B IS1980 B IS 1980B
Authority
IS
Iceland
Prior art keywords
melatonin
drug addicts
treat drug
treat
addicts
Prior art date
Application number
IS4532A
Other languages
Icelandic (is)
Other versions
IS4532A (en
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of IS4532A publication Critical patent/IS4532A/en
Publication of IS1980B publication Critical patent/IS1980B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4532A 1995-02-01 1997-07-25 Use of Melatonin to treat drug addicts IS1980B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
IS4532A IS4532A (en) 1997-07-25
IS1980B true IS1980B (en) 2005-01-14

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4532A IS1980B (en) 1995-02-01 1997-07-25 Use of Melatonin to treat drug addicts

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782266B2 (en) 2000-01-05 2005-07-14 Neurim Pharmaceuticals (1991) Ltd. Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US8785492B2 (en) 2012-01-26 2014-07-22 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
AU2013361459A1 (en) 2012-12-18 2015-07-02 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
RS61024B1 (en) * 2016-10-31 2020-12-31 Neurim Pharma 1991 Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134789T3 (en) * 1991-05-09 1999-10-16 Neurim Pharma 1991 COMPOSITIONS CONTAINING MELATONIN.
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
DK89697A (en) 1997-07-30
NO973531D0 (en) 1997-07-31
WO1996023496A1 (en) 1996-08-08
FI973185A0 (en) 1997-07-31
BG101803A (en) 1998-04-30
SK284521B6 (en) 2005-05-05
LV11940A (en) 1998-01-20
TR199700723T1 (en) 1998-02-21
LU90118B1 (en) 1997-11-13
JP4516159B2 (en) 2010-08-04
NO973531L (en) 1997-09-30
AU4457496A (en) 1996-08-21
ATA901396A (en) 2001-02-15
PL321630A1 (en) 1997-12-08
NZ298878A (en) 1999-05-28
PL183148B1 (en) 2002-05-31
LV11940B (en) 1998-05-20
JPH10513177A (en) 1998-12-15
MD970254A (en) 1999-05-31
DK176081B1 (en) 2006-04-18
CZ291349B6 (en) 2003-02-12
MX9705856A (en) 1998-07-31
FI119586B (en) 2009-01-15
FI973185L (en) 1997-09-30
BR9607169A (en) 1997-11-11
BG62876B1 (en) 2000-10-31
AU695366B2 (en) 1998-08-13
EE9700166A (en) 1998-02-16
CZ240597A3 (en) 1998-01-14
TW483757B (en) 2002-04-21
SI9620022A (en) 1998-10-31
MD1716B2 (en) 2001-08-31
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
EE03384B1 (en) 2001-04-16
MD1716C2 (en) 2002-02-28
AT408188B (en) 2001-09-25
CN1083263C (en) 2002-04-24
CN1172431A (en) 1998-02-04
SK103097A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
PT851855E (en) ACIDATED DERIVATIVES OF MELATONIN AND UTILIAN ANALOGS AS MEDICINES
DE69633333D1 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC SUBSTANCES
IT1283046B1 (en) PROCEDURE TO RECOGNIZE LACK OF COMBUSTION
DE69530004D1 (en) TRANSDERMAL ADMINISTRATION OF APOMORPHINE
NO973928L (en) Treatment of oil well
LV11895A (en) Derivatives of 4-benzoylpyrazole and their use as herbicides
NO982172D0 (en) Use of epinastine for the treatment of pain
NO965377L (en) Indolinone compounds for the treatment of diseases
NO20001479L (en) Treatment of behavioral disorder
ID18679A (en) USE OF FURTHER THERAPY
IT1283827B1 (en) PROCEDURE TO RECOGNIZE LACK OF COMBUSTION
DE59500266D1 (en) Transdermal therapeutic system for the application of naloxone
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
LV11971A (en) Derivatives of pyrrolidinohydroxamba and their yield
NO975718D0 (en) Treatment of insulin resistance
IS1980B (en) Use of Melatonin to treat drug addicts
IS4528A (en) Bicyclic derivatives of isothio urea useful therapeutic treatment
FI973023L (en) Combined therapeutic treatment of hypertrophic disorders
NO995231D0 (en) Therapeutic treatment of skin disorders
FI971527A7 (en) Use of indole derivatives for the treatment of various diseases
NO964915D0 (en) Transdermal delivery of antiepileptic drugs
FR2757059B1 (en) NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES
NO981866L (en) Therapeutic use of hemoglobin to promote wound healing
IT1282569B1 (en) PROCEDURE TO RECOGNIZE LACK OF COMBUSTION
NO982562D0 (en) Composition for the treatment of pain